top of page

Vaccine R&D

Secondary Colour.png

BK-SE36/CpG

Osaka Universty

Malaria

Type

Route

BK-SE36 is a blood-stage vaccine, formulated with K3 CpG adjuvant (BK-SE36/CpG).

Status

Target

Recombinant protein vaccine

Intramuscular

Clinical development

Projects

Plasmodium falciparum (Blood- stage)

Funders

GHIT

bottom of page